Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: Impact on in vitro parasite developmental cycle and metabolic enzyme activities

Infection, Genetics and Evolution

Volumn 6, Issue 3, 2006, Pages 187-197

  Holzmuller, Philippe ^a   Hide, Mallorie ^b   Sereno, Denis ^a   Lemesre, Jean Loup ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

6PGDH; Apoptosis; Chemoresistance; cis Aconitase; Developmental cycle; Enzyme overexpression; G3PDH; Leishmania; Nitric oxide

Indexed keywords

ACONITATE HYDRATASE; ANTIMONY TARTRATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NITRIC OXIDE; NITRIC OXIDE DONOR; PHOSPHOGLUCONATE DEHYDROGENASE;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; ENZYME ACTIVITY; FEMALE; GLYCOLYSIS; IN VITRO STUDY; LEISHMANIA INFANTUM; MICROBIAL METABOLISM; MICROBIAL RESPIRATION; MOUSE; MUTANT; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION; WILD TYPE;

ACONITATE HYDRATASE; ANIMALS; APOPTOSIS; DRUG RESISTANCE; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); INTERFERON TYPE II; LEISHMANIA INFANTUM; LIFE CYCLE STAGES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTATION; NITRIC OXIDE; NITRITES; PHOSPHOGLUCONATE DEHYDROGENASE; SELECTION (GENETICS);

ANIMALIA; LEISHMANIA INFANTUM;

EID: 33645575981     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2005.03.003     Document Type: Article

References (59)

1. A. Adhuna P. Saltora R. Bhatnagar Nitric oxide induced expression of stress proteins in virulent and avirulent promastigotes of Leishmania donovani Immunol. Lett. 71 2000 171-176
2. P. Agnew P. Holzmuller Y. Michalakis D. Sereno J.L. Lemesre F. Renaud In vitro growth of Leishmania amazonensis promastigotes resistant to pentamidine is dependent on interactions among strains Antimicrob. Agents Chemother. 45 2001 1928-1929
3. C.B. Allen X.L. Guo C.W. White Changes in pulmonary expression of hexokinase and glucose transporter mRNAs in rats adapted to hyperoxia Am. J. Physiol. 274 1998 320-329
4. C. Anacleto M.C. Abdo A.V. Ferreira S.M. Murta A.J. Romanha A.P. Fernandes E.S. Moreira Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line Parasitol. Res. 90 2003 110-118
5. F.M. Balestieri A.R. Queiroz C. Scavone V.M. Costa M. Barral-Netto A. Abrahamsohn Ide Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages Microbes Infect. 4 2002 23-29
6. M.P. Barret The pentose phosphate pathway and parasitic protozoa Parasitol. Today 13 1997 11-16
7. H. Beinert M.C. Kennedy Aconitase, a two-faced protein: Enzyme and iron regulatory factor FASEB J. 7 1993 1442-1449
8. S. Ben Abderrazak F. Guerrini F. Mathieu-Daude P. Truc K. Neubauer K. Lewicka C. Barnabe M. Tibayrenc Isoenzyme electrophoresis for parasite characterization Meth. Mol. Biol. 21 1993 361-382
9. S. Bisti G. Konidou F. Papageorgiou G. Milon J.R. Boelaert K. Soteriadou The outcome of Leishmania major experimental infection in BALB/c mice can be modulated by exogenously delivered iron Eur. J. Immunol. 30 2000 3732-3740
10. O. Bottasso J. Cabrini R. Falcoff E. Falcoff Successful treatment of an antimony-resistant American mucocutaneous leishmaniasis: A case report Arch. Dermatol. 128 1992 996-997
11. L.R. Brunet Nitric oxide in parasitic infections Int. Immunopharmacol. 1 2001 1457-1467
12. M.J. Chiquero J.M. Perez-Victoria F. O'Valle J.M. Gonzalez-Ros R.G. del Moral J.A. Ferragut S. Castanys F. Gamarro Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line Biochem. Pharmacol. 55 1998 131-139
13. M. Colasanti L. Gradoni M. Mattu T. Persichini L. Salvati G. Venturini P. Ascenzi Molecular bases for the anti-parasitic effect of NO (review) Int. J. Mol. Med. 9 2002 131-134
14. P.R. Crocker J.M. Blackwell D.J. Bradley Expression of the natural resistance gene Lsh in resident liver macrophages Infect. Immun. 43 1984 1033-1040
15. P.R. Crocker E.V. Davies J.M. Blackwell Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovani Parasite Immunol. 9 1987 705-719
16. C. Dardonville E. Rinaldi S. Hanau M.P. Barret R. Brun I.H. Gilbert Synthesis and biological evaluation of substrate-based inhibitors of 6-phophogluconate dehydrogenase as potential drugs against African trypanosomiasis Bioorg. Med. Chem. 11 2003 3205-3214
17. R. Durand M. Paul F. Pratlong D. Rivollet M.L. Dubreuil-Lemaire R. Houin A. Astier M. Deniau Leishmania infantum: Lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis Antimicrob. Agents Chemother. 42 1998 2141-2143
18. F. Feger H. Ferry-Dumazet M. Mamani Matsuda J. Bordenave M. Dupouy A.K. Nussler M. Arock L. Devevey J. Nafziger J.J. Guillosson J. Reiffers M.D. Mossalayi Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide Cancer Res. 61 2001 5289-5294
19. H. Ferry-Dumazet M. Mamani-Matsuda M. Dupouy F. Belloc D. Thiolat G. Marit M. Arock J. Reiffers M.D. Mossalayi Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: Evidence for the chelation of intracellular iron Leukemia 16 2002 708-715
20. C. Guimond N. Trudel C. Brochu N. Marquis A. El Fadili R. Peytavi G. Briand D. Richard N. Messier B. Papadopoulou J. Corbeil M.G. Bergeron D. Legare M. Ouellette Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays Nucleic Acids Res. 31 2003 5886-5896
21. N. Gupta N. Goyal A.K. Rastogi In vitro cultivation and characterization of axenic amastigotes of Leishmania Trends Parasitol. 17 2001 150-153
22. A. Haimeur C. Guimond S. Pilote R. Mukhopadhyay B.P. Rosen R. Poulin M. Ouellette Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania Mol. Microbiol. 34 1999 726-735
23. K.A. Harrington C.E. Hormaeche Expression of the innate resistance gene Ity in mouse Kupffer cells infected with Salmonella typhimurium in vitro Microb. Pathog. 1 1986 269-274
24. P. Holzmuller D. Sereno M. Cavaleyra I. Mangot S. Daulouede P. Vincendeau J.L. Lemesre Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes Infect. Immun. 70 2002 3727-3735
25. Holzmuller, P., Sereno, D., Lemesre, J.L., in press. Trivalent antimonyl-resistant amastigotes of Leishmania infantum resist NO-induced apoptotic cell death.
26. D.E. Kuhn B.D. Baker W.P. Lafuse B.S. Zwilling Differential iron transport into phagosomes isolated from the RAW 264.7 macrophage cell lines transfected with Nramp1Gly169 or Nramp1Asp169 J. Leuk. Biol. 66 1999 113-119
27. C. Kundig A. Haimeur D. Legare B. Papadopoulou M. Ouellette Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae EMBO J. 18 1999 2342-2351
28. 2 and NO stresses Biochem. J. 364 2002 349-359
29. L. Le Moyec O. Legrand V. Larue M. Kawakami J.P. Marie F. Calvo E. Hantz E. Taillandier Magnetic resonance spectroscopy of cellular lipid extracts from sensitive, resistant and reverting K562 cells and flow cytometry for investigating the P-glycoprotein function in resistance reversion NMR Biomed. 13 2000 92-101
30. J.L. Lemesre M.P. Blanc P. Grebaut V. Zilberfarb V. Carrière Culture continue des formes amastigotes de leishmanies en condition axénique Réalisation du cycle évolutif in vitro. Médecine et Armée 22 1994 99-100
31. J.L. Lemesre D. Sereno S. Daulouède B. Veyret N. Brajon P. Vincendeau Leishmania spp.: Nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms Exp. Parasitol. 86 1997 58-68
32. F.Y. Liew F.E. Cox Non-specific defence mechanism: The role of nitric oxide Immunol. Today 12 1991 17-21
33. E. Linares O. Augusto S.C. Barao S. Giorgio Leishmania amazonensis infection does not inhibit systemic nitric oxide levels elicited by lipopolysaccharide in vivo J. Parasitol. 86 2000 78-82
34. J. Mauel A. Ransijn Leishmania spp.: Mechanisms of toxicity of nitrogen oxidation products Exp. Parasitol. 87 1997 98-111
35. M.D. Mossalayi M. Arock D. Mazier P. Vincendeau I. Vouldoukis The human immune response during cutaneous leishmaniasis: NO problem Parasitol. Today 15 1999 342-345
36. C. Nathan M.U. Shiloh Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens P.N.A.S. U.S.A. 97 2000 8841-8848
37. S. Pal A. Mandal S. Duttagupta Studies on stibanate resistant Leishmania donovani isolates of Indian origin Indian J. Exp. Biol. 39 2001 249-254
38. M.A. Panaro A. Acquafredda S. Lisi D.D. Lofrumento V. Mitolo M. Sisto A. Fasanella F. Bertani B. Consenti O. Brandonisio Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes Comp. Immunol. Microbiol. Infect. Dis. 24 2001 187-195
39. M.A. Panaro A. Acquafredda S. Lisi D.D. Lofrumento T. Trotta R. Satalino M. Saccia V. Mitolo O. Brandonisio Inducible nitric oxide synthase and nitric oxide production in Leishmania infantum-infected human macrophages stimulated with interferon-gamma and bacterial lipopolysaccharide Int. J. Clin. Lab. Res. 29 1999 122-127
40. R.D. Pearson D.A. Wheeler L.H. Harrison H.D. Kay The immunobiology of leishmaniasis Rev. Infect. Dis. 5 1983 907-927
41. A. Piani T. Ilg A.G. Elefanty J. Curtis E. Handman Leishmania major proteophosphoglycan is expressed by amastigotes and has an immunomodulatory effect on macrophage function Microbes Infect. 1 1999 589-599
42. E. Pinelli D. Gebhard A.M. Mommaas M. van Hoeij J.A. Langermans E.J. Ruitenberg V.P. Rutten Infection of a canine macrophage cell line with Leishmania infantum: Determination of nitric oxide production and anti-leishmanial activity Vet. Parasitol. 92 2000 181-189
43. E. Pinelli R. Killick-Kendrick J. Wagenaar W. Bernadina G. del Real J. Ruitenberg Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum Infect. Immun. 62 1994 229-235
44. B.J. Richardson P.R. Baverstock M. Adams Allozyme Electrophoresis. A Hanbook for Animal Systematics and Population Studies 1986 Academic Press Inc.
45. J.B. Roy R.G. Wilkerson Fallibility of Griess (nitrite) test Urology 23 1984 270-271
46. L. Salvati M. Mattu M. Colasanti A. Scalone G. Venturini L. Gradoni P. Ascenzi NO donors inhibit Leishmania infantum cysteine proteinase activity Biochim. Biophys. Acta 1545 2001 357-366
47. H. Sawada S. Shimohama T. Kawamura A. Akaike Y. Kitamura T. Taniguchi J. Kimura Mechanism of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons J. Neurosci. Res. 46 1996 509-518
48. P. Scott IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis J. Immunol. 147 1991 3149-3155
49. M. Segovia Leishmania gene amplification: A mechanism of drug resistance Ann. Trop. Med. Parasitol. 88 1994 123-130
50. D. Sereno J.L. Lemesre Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents Antimicrob. Agents Chemother. 41 1997 972-976
51. D. Sereno M. Cavaleyra K. Zemzoumi S. Maquaire A. Ouaissi J.L. Lemesre Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action Antimicrob. Agents Chemother. 42 1998 3097-3102
52. D. Sereno E. Guilvard S. Maquaire M. Cavaleyra P. Holzmuller A. Ouaissi J.L. Lemesre Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas Acta Tropica 80 2001 195-205
53. D. Sereno P. Holzmuller J.L. Lemesre Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum Acta Tropica 74 2000 25-31
54. S. Stenger N. Donhauser H. Thuring M. Rollinghoff C. Bogdan Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase J. Exp. Med. 183 1996 1501-1514
55. M. Terao M. Kurosaki G. Saltini S. Demontis M. Marini M. Salmona E. Garattini Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase J. Biol. Chem. 275 2000 30690-30700
56. I. Vouldoukis P.A. Becherel V. Riveros-Moreno M. Arock O. da Silva P. Debre D. Mazier M.D. Mossalayi Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation Eur. J. Immunol. 27 1996 860-865
57. I. Vouldoukis V. Riveros-Moreno B. Dugas F. Ouaaz P. Becherel P. Debre S. Moncada M.D. Mossalayi The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen P.N.A.S. U.S.A. 92 1995 7804-7808
58. J.K. White P. Mastroeni J.F. Popoff C.A. Evans J.M. Blackwell Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity J. Leuk. Biol. 77 2005 311-320
59. S. Yan P.J. Myler K. Stuart Tetracycline regulated gene expression in Leishmania donovani Mol. Biochem. Parasitol. 112 2001 61-69